| F573 Ia Clinical Trial (NCT04820049) | Beijing Continent Pharmaceutical Co, Ltd. | 2021-02-08 |
| Safety and Pharmacokinetics of Oral Controlled-ileocolonic-release Nicotinamide (CICR-NAM) (NCT05258474) | University Hospital Schleswig-Holstein | 2020-12-04 |
| Safety, Tolerability, and Pharmacokinetics of Single Ascending Oral Doses of INV-101 in Healthy Male and Female Subjects (NCT04531150) | Inversago Pharma Inc. | 2020-09-08 |
| A Pharmacokinetic Study of PLENVU® in Healthy Subjects (NCT03437265) | Norgine | 2020-09-03 |
| Effects of Metabolic Enzymes and Transporter Gene Polymorphisms on the Pharmacokinetics and Metabolism of Oral Abiraterone Acetate in Healthy Chinese Adults (NCT04735913) | Zhongnan Hospital | 2020-05-05 |
| A Study to Compare Pharmacokinetic and Safety Profiles of Different Formulations of SHR-1314 After Subcutaneous Injection in Healthy Subjects (NCT04326881) | Jiangsu HengRui Medicine Co., Ltd. | 2020-04-07 |
| A Study in Healthy Subjects to Evaluate Pharmacokinetics and Food Effect After Dosing of GS-248 (NCT04617509) | Gesynta Pharma AB | 2020-03-31 |
| Clinical Trial on Pharmacokinetic and Tolerability of AP701 (NCT04708795) | CannaXan GmbH | 2020-01-11 |
| Citrate Pharmacokinetics in Critically Ill Liver Failure Patients Receiving CRRT (NCT04959110) | Chulalongkorn University | 2019-07-01 |
| Pharmacokinetic and Tolerance Study of TQ-A3326 in Healthy Participants. (NCT03714568) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2018-11-11 |
| Pharmacokinetic Study of Adoport® (Tacrolimus) in Patients With de Novo Kidney Transplantation (NCT03076151) | University Hospital, Limoges | 2018-02-12 |
| Clinical Outcome Study of High-dose Meropenem in Sepsis and Septic Shock Patients (NCT03344627) | Mahidol University | 2017-11-27 |
| Pharmacokinetics of Nalbuphine After Intravenous and Intranasal Administration in Infants (NCT03059511) | University Children's Hospital, Zurich | 2017-03-03 |
| Study of Artemether-lumefantrine, Amodiaquine and Primaquine in Healthy Subjects (NCT02696954) | University of Oxford | 2016-11-18 |
| To Investigate PK and PD of CJ-12420, Clarithromycin, Amoxicillin After Multiple Dose Administration (NCT03011996) | HK inno.N Corporation | 2016-05-01 |
| Evaluation of the Effects of Multiple Doses of Cebranopadol on the Electrical Activity of the Heart in Healthy Subjects (NCT03958123) | Tris Pharma, Inc. | 2013-07-10 |
| A Clinical Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of Cebranopadol (NCT03882762) | Tris Pharma, Inc. | 2013-06-20 |
| A Study In Healthy People Of Multiple Doses Of UK-396,082 Given By Mouth, To Investigate The Safety, Toleration And Time Course Of Blood Concentration Of UK-396,082 And Its Effects. (NCT01091532) | Pfizer | 2010-03-01 |
| Cytochrome P450 2C19 Variant is Related to Pharmacokinetics of Glipizide Extended Release Tablet in Chinese Subjects (NCT01082796) | Chinese Academy of Sciences | 2009-11-01 |
| Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Relative to That From the Co-administration of ABT-335 and Rosuvastatin Calcium (NCT00681395) | AstraZeneca | 2008-05-01 |
| Multi-Centre, Open-Label, Two Segment, Study Comparing Plasma Pharmacokinetics of Ketoprofen in Diractin® Alone to Diractin® Applied Concomitant With Heat or Moderate Exercise (NCT00745264) | IDEA AG | 2007-10-01 |
| Drug-drug Interaction Study to Evaluate the Effect of Omeprazole on CG5503 (Tapentadol) (NCT03979989) | Grünenthal GmbH | 2005-09-28 |
| Effect of a Multiple-dose Oral Administration of CG5503 PR on the Electrical Activity of the Heart in 48 Healthy Men and Women (NCT03951402) | Grünenthal GmbH | 2003-03-01 |